AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
AbbVie (ABBV) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, January 15, 2025, at 10:15 a.m. Central time.
Investors and interested parties can access a live audio webcast of the presentation through AbbVie's Investor Relations website at investors.abbvie.com. For those unable to attend the live session, an archived version will be made available later the same day.
AbbVie (ABBV) ha annunciato la sua prossima partecipazione al 43° Congresso Annuale J.P. Morgan Healthcare. La direzione dell'azienda parteciperà a una chiacchierata informale il mercoledì 15 gennaio 2025, alle 10:15 ora centrale.
Investitori e parti interessate potranno accedere a una diretta audio della presentazione tramite il sito di Relazioni con gli Investitori di AbbVie su investors.abbvie.com. Per coloro che non possono partecipare alla sessione dal vivo, una versione registrata sarà disponibile più tardi lo stesso giorno.
AbbVie (ABBV) ha anunciado su próxima participación en la 43ª Conferencia Anual de Salud J.P. Morgan. La dirección de la empresa participará en una charla informal el miércoles 15 de enero de 2025, a las 10:15 a.m. hora central.
Los inversores y partes interesadas podrán acceder a una transmisión de audio en vivo de la presentación a través del sito de Relaciones con Inversores de AbbVie en investors.abbvie.com. Para quienes no puedan asistir a la sesión en vivo, se hará disponible una versión grabada más tarde ese mismo día.
AbbVie (ABBV)는 제43회 연례 J.P. Morgan 헬스케어 컨퍼런스에 곧 참석할 예정이라고 발표했습니다. 회사의 경영진은 2025년 1월 15일 수요일 오전 10:15 중앙 표준시에 비공식 대화에 참여할 것입니다.
투자자와 관심 있는 당사자는 AbbVie의 투자자 관계 웹사이트인 investors.abbvie.com을 통해 발표의 라이브 오디오 웹캐스트에 접근할 수 있습니다. 실시간 세션에 참석할 수 없는 분들을 위해 같은 날 나중에 아카이브 버전이 제공될 예정입니다.
AbbVie (ABBV) a annoncé sa prochaine participation à la 43ème Conférence Annuelle J.P. Morgan Healthcare. La direction de l'entreprise participera à une discussion informelle le mercredi 15 janvier 2025, à 10h15 heure centrale.
Les investisseurs et les parties intéressées pourront accéder à un webcast audio en direct de la présentation via le site des Relations Investisseurs d'AbbVie sur investors.abbvie.com. Pour ceux qui ne peuvent pas assister à la session en direct, une version archivée sera disponible plus tard dans la journée.
AbbVie (ABBV) hat seine bevorstehende Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Das Management des Unternehmens wird am Mittwoch, den 15. Januar 2025, um 10:15 Uhr Central Time an einem informellen Gespräch teilnehmen.
Investoren und interessierte Parteien können über die Investor Relations-Website von AbbVie unter investors.abbvie.com auf ein Live-Audio-Webcast der Präsentation zugreifen. Für diejenigen, die nicht an der Livesitzung teilnehmen können, wird später am selben Tag eine aufgezeichnete Version verfügbar sein.
- None.
- None.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302346551.html
SOURCE AbbVie
FAQ
When is AbbVie (ABBV) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch AbbVie's presentation at the J.P. Morgan Healthcare Conference?
What type of presentation will ABBV give at the J.P. Morgan Healthcare Conference?